PROCARE PHARMACY, L.L.C.
NPI: 1518039858
· HONOLULU, HI 96819
· Community/Retail Pharmacy
· NPI assigned 11/14/2006
Billing Flags
· Automated signals — not evidence of fraud
Entity Proliferation
Authorized official AYCOCK, BRANDON controls 13+ related entities in our dataset. Read more
$41.83M
Total Medicaid Paid
Provider Details
| Authorized Official | AYCOCK, BRANDON (PRESIDENT) |
| NPI Enumeration Date | 11/14/2006 |
Related Entities
Other providers sharing the same authorized official: AYCOCK, BRANDON
| Provider | City | State | Total Paid |
|---|
| PROCARE PHARMACY DIRECT, LLC. |
MONROEVILLE |
PA |
$227.31M |
| CAREMARK, L.L.C. |
MT PROSPECT |
IL |
$34.08M |
| CAREMARK, L.L.C. |
REDLANDS |
CA |
$19.87M |
| CAREMARK, L.L.C. |
TAMPA |
FL |
$7.28M |
| CAREMARK, L.L.C. |
FAIRFIELD |
NJ |
$3.43M |
| CAREMARK L.L.C. |
RALEIGH |
NC |
$2.69M |
| CAREMARK L.L.C. |
LENEXA |
KS |
$2.54M |
| CAREMARK, L.L.C. |
MILFORD |
MA |
$2.20M |
| CAREMARK, L.L.C. |
BARTLETT |
TN |
$1.96M |
| PROCARE PHARMACY, LLC. |
BIRMINGHAM |
AL |
$623K |
| PROCARE PHARMACY, L.L.C. |
PORTLAND |
ME |
$109K |
| PROCARE PHARMACY LLC |
BOSTON |
MA |
$724.47 |
| CAREMARK, LLC |
MT. PROSPEC |
IL |
$76.40 |
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
3,019 |
$7.80M |
| 2019 |
2,508 |
$4.61M |
| 2020 |
2,022 |
$3.60M |
| 2021 |
2,110 |
$4.40M |
| 2022 |
2,140 |
$5.36M |
| 2023 |
2,391 |
$7.43M |
| 2024 |
2,211 |
$8.63M |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J3590 |
Unclassified biologics |
6,223 |
5,571 |
$27.39M |
| J3490 |
Unclassified drugs |
4,078 |
3,807 |
$8.61M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
3,064 |
2,993 |
$2.85M |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
2,321 |
2,275 |
$2.22M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
591 |
554 |
$591K |
| 90782 |
|
38 |
27 |
$103K |
| J7296 |
Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
45 |
43 |
$40K |
| J3031 |
Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) |
41 |
39 |
$25K |